157 related articles for article (PubMed ID: 36683930)
1. Comparison of autologous blood prolotherapy and 25% dextrose prolotherapy for the treatment of chronic recurrent temporomandibular joint dislocation on the basis of clinical parameters: A retrospective study.
Pandey SK; Baidya M; Srivastava A; Garg H
Natl J Maxillofac Surg; 2022; 13(3):398-404. PubMed ID: 36683930
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Efficacy of Different Concentrations of Dextrose Prolotherapy in Temporomandibular Joint Hypermobility Treatment.
Mustafa R; Güngörmüş M; Mollaoğlu N
J Craniofac Surg; 2018 Jul; 29(5):e461-e465. PubMed ID: 29533255
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial.
Refai H; Altahhan O; Elsharkawy R
J Oral Maxillofac Surg; 2011 Dec; 69(12):2962-70. PubMed ID: 21757278
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Autologous Blood Injection and Dextrose Prolotherapy in the Treatment of Chronic Recurrent Temporomandibular Dislocation: A Randomized Clinical Trial.
Chhapane A; Wadde K; Sachdev SS; Barai S; Landge J; Wadewale M
J Maxillofac Oral Surg; 2024 Apr; 23(2):278-284. PubMed ID: 38601242
[TBL] [Abstract][Full Text] [Related]
5. Application of auriculotemporal nerve block and dextrose prolotherapy in exercise therapy of TMJ closed lock in adolescents and young adults.
Zhou H; Xue Y; Liu P
Head Face Med; 2021 Mar; 17(1):11. PubMed ID: 33773589
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: A systematic review and meta-analysis.
Nagori SA; Jose A; Gopalakrishnan V; Roy ID; Chattopadhyay PK; Roychoudhury A
J Oral Rehabil; 2018 Dec; 45(12):998-1006. PubMed ID: 30024045
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of autologous conditioned serum versus dextrose prolotherapy in internal derangement of the TMJ - A pilot study.
Ravikumar C; Sasikala B; Krishnakumar Raja VB; Elavenil P
J Craniomaxillofac Surg; 2024 Apr; 52(4):477-483. PubMed ID: 38368212
[TBL] [Abstract][Full Text] [Related]
8. Botulinum Toxin Versus Dextrose Prolotherapy: Which is More Effective for Temporomandibular Joint Subluxation? A Randomized Clinical Trial.
Cömert Kiliç S; Kiliç N; Güngörmüş M
J Oral Maxillofac Surg; 2023 Apr; 81(4):389-395. PubMed ID: 36693543
[TBL] [Abstract][Full Text] [Related]
9. Short-term results of prolotherapy in the management of temporomandibular joint dislocation.
Ungor C; Atasoy KT; Taskesen F; Cezairli B; Dayisoylu EH; Tosun E; Senel FC
J Craniofac Surg; 2013 Mar; 24(2):411-5. PubMed ID: 23524704
[TBL] [Abstract][Full Text] [Related]
10. Long-term therapeutic effects of dextrose prolotherapy in patients with hypermobility of the temporomandibular joint: a single-arm study with 1-4 years' follow up.
Refai H
Br J Oral Maxillofac Surg; 2017 Jun; 55(5):465-470. PubMed ID: 28460873
[TBL] [Abstract][Full Text] [Related]
11. Is dextrose prolotherapy superior to placebo for the treatment of temporomandibular joint hypermobility? A randomized clinical trial.
Cömert Kiliç S; Güngörmüş M
Int J Oral Maxillofac Surg; 2016 Jul; 45(7):813-9. PubMed ID: 26846795
[TBL] [Abstract][Full Text] [Related]
12. Single Injection Technique Prolotherapy for Hypermobility Disorders of TMJ Using 25 % Dextrose: A Clinical Study.
Majumdar SK; Krishna S; Chatterjee A; Chakraborty R; Ansari N
J Maxillofac Oral Surg; 2017 Jun; 16(2):226-230. PubMed ID: 28439165
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Prolotherapy in Temporomandibular Joint Disorders: An Exploratory Study.
Dasukil S; Shetty SK; Arora G; Degala S
J Maxillofac Oral Surg; 2021 Mar; 20(1):115-120. PubMed ID: 33584052
[TBL] [Abstract][Full Text] [Related]
14. Autologous blood injection as a new treatment modality for chronic recurrent temporomandibular joint dislocation.
Daif ET
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jan; 109(1):31-6. PubMed ID: 19926503
[TBL] [Abstract][Full Text] [Related]
15. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation.
Zhou H; Hu K; Ding Y
Br J Oral Maxillofac Surg; 2014 Jan; 52(1):63-6. PubMed ID: 24064304
[TBL] [Abstract][Full Text] [Related]
16. Results of Combined, Single-Session Arthrocentesis and Dextrose Prolotherapy for Symptomatic Temporomandibular Joint Syndrome: A Case Series.
Cezairli B; Sivrikaya EC; Omezli MM; Ayranci F; Seyhan Cezairli N
J Altern Complement Med; 2017 Oct; 23(10):771-777. PubMed ID: 29017019
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Preliminary Randomized Clinical Study to Evaluate Heavy Bupivacaine Dextrose Prolotherapy (HDP) and Autologous Blood Injection (ABI) for Symptomatic Temporomandibular Joint Hypermobility Disorder.
Bhargava D; Sivakumar B; Bhargava PG
J Maxillofac Oral Surg; 2023 Mar; 22(1):110-118. PubMed ID: 36703672
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobility.
Taşkesen F; Cezairli B
Cranio; 2023 Sep; 41(5):423-431. PubMed ID: 33326351
[TBL] [Abstract][Full Text] [Related]
19. Dextrose prolotherapy for pain and dysfunction of the TMJ reducible disc displacement: A randomized, double-blind clinical study.
Haggag MA; Al-Belasy FA; Said Ahmed WM
J Craniomaxillofac Surg; 2022 May; 50(5):426-431. PubMed ID: 35501215
[TBL] [Abstract][Full Text] [Related]
20. Arthrocentesis followed by intra-articular autologous blood injection for the treatment of recurrent temporomandibular joint dislocation.
Bayoumi AM; Al-Sebaei MO; Mohamed KM; Al-Yamani AO; Makrami AM
Int J Oral Maxillofac Surg; 2014 Oct; 43(10):1224-8. PubMed ID: 24951179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
